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ABSTRACT
Trypanosoma brucei undergoes an essential
process of mitochondrial uridine insertion and
deletion RNA editing catalyzed by a 20S editosome.
The multiprotein mitochondrial RNA-binding
complex 1 (MRB1) is emerging as an equally essen-
tial component of the trypanosome RNA editing ma-
chinery, with additional functions in gRNA and
mRNA stabilization. The distinct and overlapping
protein compositions of reported MRB1 complexes
and diverse MRB1 functions suggest that the
complex is composed of subcomplexes with
RNA-dependent and independent interactions. To
determine the architecture of the MRB1 complex,
we performed a comprehensive yeast two-hybrid
analysis of 31 reported MRB1 proteins. We also
used in vivo analyses of tagged MRB1 components
to confirm direct and RNA-mediated interactions.
Here, we show that MRB1 contains a core
complex comprised of six proteins and maintained
by numerous direct interactions. The MRB1 core as-
sociates with multiple subcomplexes and proteins
through RNA-enhanced or RNA-dependent inter-
actions. These findings provide a framework for in-
terpretation of previous functional studies and
suggest that MRB1 is a dynamic complex that co-
ordinates various aspects of mitochondrial gene
regulation.
INTRODUCTION
The Order Kinetoplastida includes numerous human and
animal pathogens such as Trypanosoma brucei, T. cruzi
and Leishmania spp., which are the causative agents of
African sleeping sickness and nagana, Chagas’ disease
and several forms of leishmaniasis, respectively. The
kinetoplastids are named for their unique mitochondrial
DNA, called the kinetoplast, which is comprised of a cat-
enated network of approximately 50 maxicircles and thou-
sands of minicircles (1). Maxicircles encode two
mitochondrial rRNAs and 18 proteins, the majority of
which are components of the respiratory complexes.
Of 18 mitochondrial mRNAs, 12 undergo post-
transcriptional modiﬁcation through an exceptional
process of RNA editing entailing speciﬁc uridine (U) in-
sertion and deletion that can double the size of the
primary transcript. U insertion/deletion editing is essential
for creation of translatable open reading frames in
kinetoplastid mitochondria (2,3). Sequence information
governing the sites and numbers of uridines to be
inserted and deleted is provided by the mostly (with two
exceptions) minicircle-encoded guide RNAs (gRNAs).
RNA editing is catalyzed by the multiprotein RNA
editing core complex (RECC), also known as the
editosome. Pre-mRNA and cognate gRNA form an
anchor duplex, with the sites to be edited located
upstream of the anchor duplex. The central region of the
gRNA then acts as the template to direct the editing by the
RECC, in a series of reactions including endonucleolytic
cleavage of the mRNA, U insertion or deletion, and RNA
ligation. Some mRNAs are minimally edited, while a
number of mRNAs are extensively edited (pan-edited)
and require dozens of gRNAs to act sequentially in the
30-t o5 0-direction along the mRNA to produce the fully
edited translatable mRNAs (2,3). In addition to the
RECC, a number of editing accessory factors are
required for efﬁcient editing. These accessory proteins
can modulate editing through substrate production, sub-
strate delivery, and editing processivity, as well as
associated gene regulatory processes including RNA
turnover. For example, MRP1/2 and RBP16 are essential
for editing of a subset of mRNAs, a function that may
involve their RNA–RNA annealing properties (4–7).
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when multiple gRNAs are involved (8). Another protein,
p22, transiently interacts with the editosome and is specif-
ically required for editing of cytochromes oxidase subunit
II (9).
A number of other accessory proteins have been
characterized, and these were either subsequently or sim-
ultaneously identiﬁed as components of an ill-deﬁned
RNA editing accessory complex. Three groups inde-
pendently identiﬁed this multiprotein accessory complex
by immunopuriﬁcation and mass spectrometry of
tagged gRNA-associated proteins, GAP1 and GAP2.
This complex was named the mitochondrial RNA-
binding complex 1 (MRB1) in T. brucei and gRNA-
binding complex (GRBC) in Leishmania major (10–12).
This MRB1/GRBC complex, hereafter called MRB1,
has an imprecisely deﬁned composition because the
initial and subsequent MRB1 puriﬁcations identiﬁed
both common and distinct components (10–14). MRB1
complex proteins characterized to date are essential for
growth and affect RNA editing directly or indirectly at
multiple steps including initiation (MRB3010,
TbRGG2), 30-t o5 0-editing progression (TbRGG2),
gRNA stabilization (GAP1/2 and REH2), as well as un-
deﬁned steps of RNA editing (Tb11.02.5390 and
Tb927.6.1680) (12,14–17). Additionally, some MRB1
pulldowns contain components of the MERS1 (mitochon-
drial edited mRNA stability) and kPAP1 (mRNA
polyadenylation) complexes (12,17). The kPAP1 complex
protein PPR1, also known as KPAF1, stimulates kPAP1
and RET1 post-editing 30 A/U long tail addition, which
marks the transcripts for translation (18). Thus, the
MRB1 complex may play a central role in coordinating
RNA editing, stability, polyadenylation and translation.
MRB1 pulldowns consistently identify a common set of
proteins; however, copuriﬁcation of other proteins varies
depending on the component of MRB1 that is tagged and
the laboratory (10–14). This variability suggests that the
MRB1 complex is composed of subcomplexes that have
different temporal and physical associations.
Characterization of the MRB1 complex is further
complicated by the RNA-dependent associations that
are likely taking place. To understand the functional
roles of this complex, we must ﬁrst determine the
physical associations that make up the MRB1 complex
and its component subcomplexes and proteins. To this
end, we undertook a large scale yeast two-hybrid
analysis to characterize direct protein–protein interactions
in the MRB1 complex. Additional afﬁnity puriﬁcations of
MRB1 components in the presence and absence of
nuclease treatment, followed by immunoblots and mass
spectrometric analysis, were used to conﬁrm associations
in vivo, and determine their RNA dependence. We identify
a core MRB1 complex containing six proteins, GAP1,
GAP2, MRB3010, MRB5390 (Tb11.02.5390), MRB8620
(Tb11.01.8620) and MRB11870 (Tb927.10.11870). The
MRB1 core complex interacts with additional
subcomplexes and proteins directly or in a manner
enhanced by the presence of RNA. Yet other proteins as-
sociate with the MRB1 complex in a completely
RNA-dependent manner. This work reveals the basic
structural architecture of the MRB1 complex, which is
essential in understanding its functions and their spatial
and temporal organization. Overall, our results suggest a
model in which the MRB1 core complex participates in
multifaceted dynamic and RNA-dependent associations
that coordinate the numerous roles of the MRB1
complex in mitochondrial RNA biogenesis and editing.
MATERIALS AND METHODS
Yeast two-hybrid screen
The complete open reading frames of 31 putative MRB1
genes were PCR ampliﬁed from either T. brucei procyclic
form (PF) strains 29–13 genomic DNA or cDNA using
Pfx (Invitrogen) or Phusion (Finnzymes) polymerase with
the primers listed in the Supplementary Materials and
Methods. PCR products were cloned into the yeast
two-hybrid Gal4 activation domain (AD) vector
pGADT7 and into the Gal4-binding domain (BD)
vectors pAS2-1 or pGBKT7 (Clontech). Binary combin-
ations of the plasmids (1mg each) were cotransformed into
the Saccharomyces cerevisiae strain PJ69-4A using the
lithium acetate method. Cotransformed yeast was plated
to synthetically deﬁned (SD) media lacking leucine (–leu)
and tryptophan (–trp), and incubated for 3 days at 30 C.
Next, 5–10 colonies of cotransformed yeast were
inoculated onto SD ( leu/ trp) media, to select for the
two cotransformed plasmids, and onto SD ( leu/ trp)
also lacking histidine ( his), to select for protein–protein
interaction. SD ( leu/ trp/ his) plates were supple-
mented with 1, 2, 3.5 and 5mM 3-amino-1,2,4-triazole
(3-AT), which inhibits PJ69-4A yeast growth due to
leaky expression of the HIS gene. The inoculated plates
were incubated 3 days at 30 C. The entire procedure was
repeated for each binary combination yielding growth.
Tagged cell line construction (plasmid construction, cell
culture, transfection)
For PTP tagging, The C-terminal 400bp of MRB6070
were cloned into the ApaI and NotI sites of pC-PTP
(19) that was previously modiﬁed to contain the puro-
mycin resistance gene (pC-PTP-PURO) (20), and the re-
sulting pC-PTP-PURO-MRB6070 was digested at the
unique MRB6070 cut site BoxI. The C-terminal 569bp
of MRB5390 were cloned into pC-PTP-PURO ApaI and
NotI sites, and the resulting pC-PTP-PURO-MRB5390
was linearized at the unique BsgI site. The C-terminal
583bp of MRB10130 were cloned into pC-PTP-PURO
HindIII and NotI sites and the resulting
pC-PTP-PURO-MRB10130 was linearized at the unique
NcoI site. The C-terminal 518bp of MRB11870 were
cloned into pC-PTP-PURO using the ApaI and NotI
sites, and the resulting pC-PTP-PURO-MRB11870 was
linearized at the unique MfeI site. All plasmids were sub-
sequently transfected into procyclic form T. brucei strain
29–13. To construct an RNAi vector for TbRGG2, a
350-nt DNA fragment corresponding to the TbRGG2
30-UTR was cloned into the BamHI and HindIII sites of
p2T7-177 vector. An amount of 50mg of NotI linearized
p2T7-177-TbRGG2 30-UTR was transfected by
5638 Nucleic Acids Research, 2012,Vol.40, No. 12electroporation into 29–13 cells, and transformants were
selected with phleomycin (2.5mg/ml). Growth effects of
TbRGG2-30-UTR RNAi were monitored for at least 10
days in the absence or presence of 2.5mg/ml tetracycline
and protein downregulation was veriﬁed by immunoblot-
ting. To construct the addback vector for myc-TbRGG2,
the entire ORF of TbRGG2 was ampliﬁed and cloned into
Zero blunt-end vector (Invitrogen). This TbRGG2
fragment was excised and cloned into HindIII and XbaI
sites of p2Myc-100 vector (21). An amount of 50mgo f
NotI linearized p2Myc-TbRGG2 was transfected into
TbRGG2-30-UTR RNAi cells. Transformants were
selected with blasticidin (20mg/ml) and downregulation
of the endogenous TbRGG2 as well as expression of the
exogenous myc-TbRGG2 was conﬁrmed by immunoblot-
ting. All primers used in this study are listed in
Supplementary Table S1.
PTP puriﬁcation and immunoprecipitation
Tandem afﬁnity puriﬁcation was carried out using
5 10
10 procyclic cells containing the PTP-tagged
proteins as described previously (19,22) except for minor
modiﬁcations. Prior to binding the IgG Sepharose 6 Fast
Flow column the supernatant was split in half. One-half
was incubated with 50U of the RNase inhibitor
SuperaseIn (Ambion). The other half was treated with a
nuclease cocktail containing RNase A (0.1U/ml), RNase
T1 (0.1U/ml), RNase H (0.01U/ml), RNase 1 (0.1U/ml),
RNase V1 (0.002U/ml), DNase 1 (0.002U/ml) and micro-
coccal nuclease (0.25U/ml) (Fermentas) for 60min on ice.
The TEV eluates from the ﬁrst step of the tandem afﬁnity
puriﬁcation were analyzed by western blot. The tandem
afﬁnity puriﬁed eluates from the anti-protein C columns
were analyzed by mass spectrometry. Myc afﬁnity puriﬁ-
cation of TbRGG2 was carried out under similar condi-
tions to the published PTP and TAP puriﬁcation schemes.
Mitochondrial extract from Day 4 TbRGG2-2myc
overexpression PF cells was incubated with anti-myc poly-
clonal antibody (ICL laboratories) cross-linked to protein
A sepharose beads (GE Healthcare) for 2h at 4  in the
presence of the SuperaseIn inhibitor and Complete
Protease inhibitor (Roche). The ﬂow through was col-
lected and the column washed extensively with PBST
(phosphate buffered saline with 0.1% NP-40). The
antibody-antigen complex was disrupted using elutions
of 100mM glycine (pH 2.5). The eluted complexes were
neutralized using 1M Tris buffer (pH 8.7) and analyzed
using western blotting.
Glycerol gradient
Mitochondria were enriched from 1 10
10
PTP-MRB3010 RNAi procyclic cells as described previ-
ously (11). The enriched mitochondria were lysed in 1ml
of the lysis buffer (10mM Tris at pH 7.2, 10mM MgCl2,
100mM KCl, 1mM DTT, 1mg/ml pepstatin, 2mg/ml
leupeptin) with 1% Triton X-100 and treated with the
nuclease cocktail described above for 60min at 4 C. The
lysate was cleared and loaded on a 11-ml 10–30% glycerol
gradient and the gradient centrifuged at 32000rpm in a
Beckman SW41 rotor for 16h at 4 C. Twelve 0.5-ml
fractions were then collected from the top and sedimenta-
tion of MRB proteins was analyzed by western blot.
Western blots
Proteins were transferred onto nitrocellulose membrane
and probed with polyclonal antibodies against GAP1
(14), GAP2 (17), TbRGG2 (23) and KREPA6 (24)
(a kind gift from Ken Stuart, Seattle BioMed) described
previously. Polyclonal antibodies were produced against
recombinant MRB11870 and the oligopeptides
CNLSNETTSDLKGKENSEESQ (MRB6070) and
CGNGPKDGTTIHSGPGGREK (MRB8170) (Bethyl
Laboratories). Anti-MRB11870 antibodies were further
afﬁnity puriﬁed against recombinant MRB11870.
Mass spectrometry
LC–MS/MS analysis was performed by Dr Yuko Ogata at
the Fred Hutchinson Cancer Research Center using LTQ
mass spectrometer (Thermo Fisher Scientiﬁc). The LC
system conﬁgured in a vented format (25) consisted of a
fused-silica nanospray needle packed in-house with Magic
C18 AQ 100A reverse-phase media (Michrom
Bioresources Inc.) and a trap containing Magic C18 AQ
200A reverse-phase media. The peptide samples were
loaded onto the column and chromatographic separation
was performed using a two-mobile-phase solvent system
consisting of 0.1% formic acid in water (A) and 0.1%
acetic acid in acetonitrile (B). The mass spectrometer
operated in a data-dependent MS/MS mode over the
m/z range of 400–1800. For each cycle, the ﬁve most
abundant ions from each MS scan were selected for MS/
MS analysis using 35% normalized collision energy.
Selected ions were dynamically excluded for 45s. For
data analysis, raw MS/MS data were submitted to the
Computational Proteomics Analysis System (CPAS), a
web-based system built on the LabKey Server (26) and
searched using the X! Tandem search engine (27) against
T. brucei protein database v. 4.0 (ftp://ftp.sanger.ac.uk/
pub/databases/T.brucei_sequences/T.brucei_genome_
v4/), which included additional common contaminants
such as human keratin. The search output ﬁles were
analyzed and validated by ProteinProphet (28). Proteins
and peptides with a probability scores of  0.9 were
accepted.
RESULTS
Identifying direct protein–protein interactions in
the MRB1 complex by yeast two-hybrid analysis
The MRB1 complex has been ascribed multiple functions
and overlapping protein compositions (10–14,16,17).
However, these functional analyses of individual
MRB1 complex components are difﬁcult to interpret
without an understanding of the RNA-dependent and
RNA-independent protein–protein interactions and
subcomplexes that comprise the large MRB1 complex.
To gain an understanding of the architecture of this
complex, or possibly a consortium of subcomplexes, we
began by performing a comprehensive yeast two-hybrid
Nucleic Acids Research, 2012,Vol.40, No. 12 5639screen to identify direct protein–protein interactions.
Here, we included 26 components reported in the three
original MRB1 (also known as GRBC) puriﬁcations
(10–12) and Tb11.01.0880, which was subsequently
isolated with the REH2 helicase (13) and MRB3010
(14). In addition, some components of the kPAP1
polyadenylation and MERS1 RNA stability complexes
were also associated with the MRB1 complex (12),
prompting us to include four additional proteins
reported to be components of the kPAP1 and/or
MERS1 (but not MRB1) complexes. A complete list of
the 31 proteins tested by yeast two-hybrid analysis is
shown in Table 1. Throughout the manuscript, we refer
to MRB1 components with the last four or ﬁve digits
of their TriTrypDB designation, preceded by MRB, or
by previously reported descriptive names. Unnamed
proteins that are kPAP1 or MERS1 components are
only listed by the last four digits of their TriTrypDB
accession number.
For yeast two-hybrid analysis, genes encoding each of
the 31 proteins were cloned into bait and prey vectors, and
the resulting plasmids were cotransformed into yeast to
screen for all 961 possible binary combinations.
Selection was carried out on SD ( leu/ trp/ his) plates
containing 1, 2, 3.5 or 5mM 3-AT to eliminate back-
ground growth and establish increasingly stringent
growth conditions. We categorized each interaction as
strong or weak based on reproducible growth patterns
as follows. Strong interactions were deﬁned as those for
which cotransformants grew robustly on plates containing
3.5mM 3-AT, and weak interactions were deﬁned as those
for which cotransformants grew on plates containing
2mM 3-AT, but not at higher 3-AT concentrations. An
example of the selection and scoring scheme is shown in
Figure 1A, where plasmid cotransformation was con-
ﬁrmed by growth on SD ( leu/ trp) and protein–
protein interaction was screened on SD ( leu/ trp/
 his) supplemented with 3-AT inhibitor. Interactions
between TbRGG2-activation domain (AD) and
MRB8180-BD, MRB8620-BD and TbRGG2-BD were
scored as strong [shown as (+) in Figure 1] based on
their robust growth at 3.5mM 3-AT. Interactions
Table 1. Trypanosoma brucei mitochondrial MRB1 and MRB1-associated proteins analyzed in the comprehensive yeast two-hybrid screen
Tb Name GeneDB # Other Name or # Complex(es) Predicted Size (kDa) LmjF homolog
MRB3010 Tb927.5.3010 MRB1 (10–14)
a,b,c,d,e 57 LmjF08.1170
MRB5390 Tb11.02.5390 MRB1 (10–14)
a,b,c,d,e 120 LmjF28.0340
MRB4160
f Tb927.4.4160 MRB1 (10–14)
a,b,c,d,e 100
g LmjF31.0640
MRB8620 Tb11.01.8620 MRB1 (10–14)
a,b,c,d,e 53
g LmjF32.3180
MRB8170
f Tb927.8.8170 MRB1 (10–14)
a,b,c,d,e 100 LmjF31.0640
TbRGG2 Tb927.10.10830 Tb10.406.0050, RGGm MRB1 (10,11,13)
a,b,d 32 LmjF33.0260
GAP1 Tb927.2.3800 GRBC2 MRB1 (10–14)
a,b,c,d,e 55 LmjF33.2730
GAP2 Tb927.7.2570 GRBC1 MRB1 (10–12,14)
a,b,c,e 52 LmjF22.0650
Helicase Tb927.4.1500 Hel1500, REH2 MRB1 (10–13)
a,b,d,e 241 LmjF34.3230
MRB11870 Tb927.10.11870 Tb10.389.1910 MRB1 (11–14)
b,c,d,e 34 LmjF33.1250
MERS1 Tb11.01.7290 NUDIX Hydrolase MERS1 (12)
e MRB1 (11)
b 44 LmjF32.2440
MRB1820 Tb927.3.1820 MRB1 (11)
b 25
g LmjF25.1740
MRB1860 Tb927.2.1860 MRB1 (10,13,14)
a,c,d 96 LmjF33.1730
MRB6070 Tb927.2.6070 MRB1 (10)
a 31
g
MRB800 Tb927.7.800 MRB1 (10,13,14)
a,c,d 60 LmjF26.1140
MRB10130 Tb927.10.10130 Tb10.6k15.0150 MRB1 (10,14)
a,c 61 LmjF36.4770
MRB8180
h Tb927.8.8180 Tb927.4.4150
h MRB1 (10,12,14)
a,c,e 103 LmjF31.0630
MRB1680 Tb927.6.1680 MRB1 (10)
a 58
g LmjF30.0260
MRB1590 Tb927.3.1590 MRB1 (10,11)
a,b 72 LmjF25.1540
MRB0880 Tb11.01.0880 MRB1 (10,13,14)
a,c,d 18 LmjF28.1810
kPAP1 Tb11.02.5820 kPAP (12)
e 58 LmjF28.0780
7510 Tb11.01.7510 kPAP (12)
e 86 LmjF32.2670
0024 Tb11.47.0024 kPAP (12)
e MERS1 (12)
e 98 LmjF27.0630
PPR5 Tb927.10.380 Tb10.70.7960 MRB1 (12)
e 39 LmjF21.1620
3180 Tb11.02.3180 MRB1 (12)
e kPAP (12)
e MERS1 (12)
e 94 LmjF24.0830
PPR1 Tb927.2.3180 kPAF1 MRB1 (12)
e kPAP (12)
e 114 LmjF18.0010
0130 Tb11.02.0130 MRB1 (12)
e kPAP (12)
e MERS1 (12)
e 84 LmjF33.2510
3900 Tb927.10.6850 Tb10.6k15.3900 MRB1 (12)
e kPAP (12)
e MERS1 (12)
e 36 LmjF36.2310
5120 Tb11.02.5120 MERS1 (12)
e 104 LmjF28.0040
MRB2140 Tb927.6.2140 Hydratase MRB1 (11,13)
b,d 28 LmjF30.0705
TbRGG1 Tb927.6.2230 RGG1 MRB1 (11)
b 88
g LmjF30.0780
MRB1 and MRB1-associated proteins identiﬁed by multiple groups in ﬁve manuscripts:
a,b,c,dProteins are identiﬁed as components of indicated complex if present after RNase treatment.
eProteins are identiﬁed as components of indicated complex if at least three peptides were identiﬁed and greater than half remained after RNase
treatment.
fBoth MRB8180/MRB4150 and MRB8170/MRB4160 are the result of a chromosomal duplication in T. brucei (but not L. major), and therefore these
two proteins have the same single L. major homolog.
gSome of the predicted sizes for the T. brucei proteins are different from those listed on TriTrypDB because of alternative initiation site utilization.
hMRB8180/MRB4150 are 99% identical and thus are considered identical for the purpose of this study.
Tb, T. brucei; LmjF, L. major.
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PPR5-BD (latter two are members of the kPAP1
complex proteins), and 0024-BD (member of the kPAP1
and MERS1 complexes) were scored as weak [shown as
(wk) in Figure 1], based on growth at 2mM, but not
3.5mM 3-AT. The TbRGG2-AD/PPR1-BD interaction
was scored as negative due to the absence of growth on
2mM 3-AT. Using this scoring system, we designated each
of the 961 binary interactions as strong, weak, or negative.
In Figure 1B, we show a summary of the interactions only
for those proteins that exhibited at least one interaction.
Of the 31 proteins tested, 19 displayed interactions in at
least one direction. The 12 proteins that showed no inter-
actions are GAP2 (Tb927.7.2570), REH2 (Tb927.4.1500),
MERS1 (Tb11.01.7290), Tb927.2.1860, Tb927.2.6070,
Tb927.7.800, Tb927.6.1680, kPAP1 (Tb11.02.5820),
Tb927.10.6850, Tb11.02.5120, Tb927.6.2140 and
TbRGG1 (Tb927.6.2230). The absence of interactions in
the yeast two-hybrid screen may reﬂect an
RNA-dependent association between a given protein and
the MRB1 complex. However, we cannot rule out that
poor protein expression or the presence of the AD or
BD tag precluded interactions in this assay.
In total, we observed 62 protein–protein interactions, 31
strong and 31 weak. Strikingly, a small number of proteins
are responsible for the majority of interactions. The
proteins MRB3010, GAP1, TbRGG2, MRB8620,
MRB8170 and MRB4160 are involved in 30 of 31
strong interactions and 24 of 31 weak interactions.
Notably, the protein MRB10130 is involved in many of
the weak interactions (Figures 1B and 3). These results
suggest these proteins are important binding partners in
the MRB1 complex.
MRB1 contains a core subcomplex
We next set out to conﬁrm a subset of the strong protein–
protein interactions identiﬁed by the yeast two-hybrid
screen using in vivo pull downs, followed by western
blot, glycerol gradient, and mass spectrometry analysis.
We generated PF T. brucei cell lines in which MRB5390
and MRB11870 were tagged at one endogenous locus with
a C-terminal PTP (Protein A-TEV cleavage-Protein C) tag
(19). We also utilized PTP-MRB3010 cell lines, which
were previously described (14). Initially, we employed all
available antibodies to detect proteins that copurify with
the PTP-tagged proteins by western blot. Extracts were
either incubated with RNase inhibitor (  RNases) or
were pretreated with a cocktail containing RNases A,
T1, V1, H and 1, DNase 1, and micrococcal nuclease
(+ RNases). Untreated and nuclease treated extracts
were subjected to IgG Sepharose chromatography and
TEV protease cleavage, a protocol that avoids RNases
that often contaminate proteins subjected to a second
afﬁnity chromatography step (29). Comparison of
copurifying proteins from both RNase inhibited and
nuclease treated extracts allows us to distinguish RNA-
dependent, RNA-enhanced and RNA-independent inter-
actions. Western blot analysis of proteins associated
with PTP-MRB3010, MRB5390 and MRB11870
revealed numerous RNA-independent protein–protein
Figure 1. Yeast two-hybrid analysis of direct interactions in the MRB1 complex. (A) Representative plates showing yeast cotransformed with bait
(BD) and prey (activation domain). Yeast cells were grown on synthetically deﬁned (SD) media ( leu/ trp) plates to select for cotransformants and
subsequently grown on SD ( leu/ trp/ his) plates with 2 or 3.5mM 3-AT to select for bait-prey interaction. Growth on 2mM 3-AT but not
3.5mM 3-AT was scored as a weak (wk) interaction, and growth on both 2 and 3.5mM 3-AT was scored as a strong (+) interaction. (B) Summary of
yeast two-hybrid results for all proteins showing at least one interaction (19 out of 31). The prey proteins are on the x-axis and the bait proteins are
on the y-axis.
Nucleic Acids Research, 2012,Vol.40, No. 12 5641interactions, several of which conﬁrmed direct interactions
detected by yeast two-hybrid screen. Afﬁnity puriﬁed
PTP-MRB3010 associated in vivo with GAP1 and
MRB11870 in an RNA-independent manner (Figure 2A,
lanes 1 and 2), consistent with the direct MRB3010-GAP1
and MRB3010-MRB11870 interactions identiﬁed by
yeast two-hybrid assay (Figures 1B and 2B). The lat-
ter interaction was corroborated by the reciprocal
RNA-independent copuriﬁcation of MRB3010 with
PTP-MRB11870 (Figure 2A, lanes 5 and 6). Western
blot analysis of afﬁnity puriﬁed PTP-MRB5390 demons-
trated an RNA-independent association between this
protein and MRB3010 (Figure 2A, lanes 3 and 4), again
supporting the direct interaction identiﬁed by yeast
two-hybrid assay.
Unexpectedly, western blot analysis of nuclease treated
extracts also revealed numerous RNA-independent inter-
actions between GAP1, GAP2, MRB3010, MRB5390 and
MRB11870 that were not detected by the yeast two-hybrid
assay. For example, we observed RNA-independent
associations between GAP2 and PTP-MRB3010, PTP-
MRB5390 and PTP-MRB11870, although GAP2
showed no two-hybrid interactions (Figure 2A, lanes
1–6). Likewise, PTP-MRB5390 and PTP-MRB11870
associated with GAP1 in an RNA-independent manner
even though these proteins lacked direct interactions by
Figure 2. The MRB1 core complex and TbRGG2 subcomplex have RNA-independent and RNA-enhanced interactions. (A) Puriﬁcation of MRB1
complexes from extracts of cells expressing PTP- or myc-tagged MRB1 components that were either nuclease treated (+ RNases) or left untreated
(  RNases). Proteins were eluted from IgG Sepharose 6 Fast Flow columns by TEV protease cleavage or immunoprecipitated with anti-myc
antibody and electrophoresed on SDS–PAGE gels, followed by immunoblot analysis using an antibody speciﬁc to protein C (to detect the
PTP-tagged proteins) or antibodies speciﬁc to MRB1 complex proteins. Asterisks indicate breakdown products. (B) Schematic representation of
all yeast two-hybrid (Y2H) strong interactions. Thin black lines represent a strong interaction in one direction, thick black lines represent strong
interactions in both directions, a thin black line with a dashed line represents a strong interaction in one direction and a weak interaction in the other
direction, and an underline represents self-interaction. The yellow star is used to indicate that the GAP1 and GAP2 interaction is based on previous
work (12,17), not yeast two-hybrid results. The MRB1 core complex is shown in blue and the TbRGG2 subcomplex is shown in green. Red dashed
lines represent RNA-independent interactions between core proteins identiﬁed in in vivo puriﬁcations in (A). (C) Glycerol gradient sedimentation of
MRB components after RNase treatment. Mitochondrial extract from PF PTPMRB3010 cells was treated with RNases and fractionated on a
10–30% glycerol gradient. Alternate gradient fractions were electrophoresed on SDS–PAGE and immunoblotted with the indicated antibodies. The
mitochondrial extract loaded on the gradient is shown on the left (abbreviated as L). Asterisks indicate breakdown products or a nonspeciﬁc band.
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results suggest that the in vivo interactions between
MRB5390, MRB11870 and GAP2 are indirect and
mediated by other proteins such as MRB3010. The
diagram in Figure 2B summarizes all strong yeast
two-hybrid interactions, which are shown with solid
black lines, and incorporates RNA-independent associ-
ations identiﬁed by in vivo tagged protein pulldowns as
shown by dashed red lines. Collectively, the yeast
two-hybrid screening and in vivo pulldown analyses
support the presence of an RNA-independent subcomplex
containing at least MRB5390, MRB3010, MRB11870,
GAP1 and GAP2, which entails numerous direct and
indirect interactions between these proteins (Figure 2B,
shown in blue). The existence of such a subcomplex is
consistent with all previous MRB1 complex pulldowns,
the majority of which contained these ﬁve proteins
[summarized in (14)]. We were not able to obtain an
antibody against MRB8620 to test its copuriﬁcation
with the subcomplex proteins by western blot. However,
yeast two-hybrid results demonstrating direct interactions
between MRB8620 and MRB5390, MRB3010 and GAP1
(Figures 1B and 2B) in combination with mass spectro-
metric analyses of MRB1 complex components performed
by our laboratories and others are consistent with
MRB8620 constituting a sixth member of the subcomplex
(Table 2) (10–14).
To further conﬁrm the core complex composition and
identify additional RNA-independent interactions within
the MRB1 complex, we performed mass spectrometric
analysis of proteins that associate with PTP-tagged
MRB5390 and MRB11870 in an RNA-independent
manner. PTP-MRB5390 and PTP-MRB11870 were
isolated from nuclease treated extracts by tandem
afﬁnity puriﬁcation via sequential IgG Sepharose chroma-
tography, TEV cleavage and mAb anti-Protein C chroma-
tography. PTP pulldowns contained likely contaminants
including characterized nuclear and cytoplasmic proteins,
and these additional proteins are listed in Supplementary
Table S2. Of the 14 unlikely contaminant proteins
identiﬁed in PTP-MRB5390 puriﬁcations, the six
proteins with the highest amino acid sequence coverage
were PTP-MRB5390 itself along with GAP1, GAP2,
MRB3010, MRB8620 and MRB11870 (Table 2). Thus,
the proposed core subcomplex components make up the
six proteins with the highest coverage. These results are
consistent with previous mass spectrometry results for
PTP-MRB3010, in which these six proteins were also
isolated with the highest amino acid coverage (14). In
MRB11870 puriﬁcations, the six core subcomplex compo-
nents were present, comprising 6 of the 10 proteins with
the highest amino acid coverage (Table 2), again support-
ing RNA-independent interactions between these proteins.
Mass spectrometry also revealed nuclease-resistant
interactions between both PTP-MRB5390 and PTP-
MRB11870 and reported MRB1 components TbRGG2,
MRB8170/4160, MRB8180, MRB10130 and MRB800. In
addition, PTP-MRB5390 copuriﬁed with MRB0880, while
PTP-MRB11870 copuriﬁed with MRB1860, possibly re-
ﬂecting speciﬁc or higher afﬁnity interactions. Taken
together, our yeast two-hybrid and in vivo copuriﬁcation
results indicate that a particle comprising MRB5390,
MRB3010, MRB11870, MRB8620, GAP1 and GAP2
constitutes an RNA-independent core subcomplex of the
larger MRB1 complex.
Next we wanted to determine if the core proteins
function only within the core subcomplex, or if they
have additional functions outside of the core. We
fractionated mitochondrial lysates from nuclease treated
PTP-MRB3010 cells on 10–30% glycerol gradients, and
analyzed MRB component sedimentation by immunoblot.
PTP-MRB3010 sediments in fractions 9–15 and endogen-
ous MRB3010 appears in fractions 11–15, which corres-
ponds to a size of <20S as compared to the 20S
editosome marker, KREPA6 (Figure 2C, bottom) (14).
A breakdown product of PTP-MRB3010 is also evident
in fractions 3–5 (Figure 2C, top, asterisk) (14). MRB11870
cosediments with both endogenous and PTP-tagged
MRB3010 primarily in fractions 11–15 (Figure 2C).
Together with the pull down results in Figure 2B, this
suggests that MRB3010 and MRB11870 exist primarily,
if not exclusively, in the MRB1 core subcomplex. In
contrast, GAP1 (and therefore its heterotetramer partner
GAP2) sediments broadly in fractions 3–13 after nuclease
treatment (Figure 2C). The small degree of cosedi-
mentation of the GAP proteins with other core complex
components suggests GAP1 and GAP2 have additional
functions outside of the core subcomplex.
TbRGG2 exhibits RNA-enhanced interactions with core
subcomplex and other proteins
TbRGG2 is an RNA-binding protein that impacts both
initiation and 30-t o5 0-progression of RNA editing (15,23).
In the yeast two-hybrid screen, TbRGG2 displayed
numerous strong interactions with both the core
subcomplex, as well as with MRB8170, MRB4160,
MRB8180 and MRB10130 (Figures 1B and 2B).
Regarding interactions with the core, in the yeast
two-hybrid screen TbRGG2 bound strongly both
MRB3010 and MRB8620 (Figure 1B). In the glycerol
gradient fractionation of nuclease treated mitochondrial
lysates TbRGG2 cosedimented in fractions 13–17 with
the core proteins MRB3010 and MRB11870 (Figure
2C). To further examine interactions between TbRGG2
and the above-described MRB1 core in vivo, we performed
anti-TbRGG2 western blots of afﬁnity puriﬁed MRB3010,
MRB5390 and MRB11870. PTP-MRB3010 pulled down
TbRGG2 in both untreated and nuclease treated extracts,
although the signal in nuclease treated extracts was
markedly diminished (Figure 2A, lanes 1 and 2). Thus,
we deﬁne the MRB3010–TbRGG2 interaction as
RNA-enhanced. Notably, PTP-MRB11870 also pulled
down TbRGG2 in an RNA-enhanced manner (Figure
2A, lanes 5 and 6), although these proteins did not
interact in the yeast two-hybrid screen. This presumably
reﬂects an indirect MRB11870–TbRGG2 interaction
mediated through MRB3010. The core protein
PTP-MRB5390 also pulled down TbRGG2 (Figure 2A,
lanes 3 and 4), although the interaction appears to be
weaker than that observed between TbRGG2 and other
core components. In addition, the MRB5390-TbRGG2
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apparent absence of signal in the nuclease treated
sample may reﬂect the overall weak signal. It is possible
that different core components interact with TbRGG2
somewhat differently, or the PTP tag on MRB5390 may
perturb its interaction with TbRGG2. Nevertheless, this
interaction is likely indirect as MRB5390 and TbRGG2
did not interact in the yeast two-hybrid screen. The
RNA-enhanced nature of the in vivo interactions
between TbRGG2 and core components is in striking
contrast to the RNA-independent interactions observed
between the core components themselves, and further
supports the composition of the core. Together, these
results suggest that TbRGG2 interacts with the core
subcomplex (through MRB3010 and perhaps MRB8620,
as suggested by yeast two-hybrid results), but it is not part
of the core.
To conﬁrm the numerous TbRGG2 interactions
detected in the yeast two-hybrid screen, we generated a
PF T. brucei line overexpressing exogenous myc-tagged
TbRGG2 in a 30-UTR-based knockdown background,
such that the tagged protein constitutes a large percentage
of mitochondrial TbRGG2. Initially, we generated a
PTP-tagged TbRGG2 cell line, but the cells had severely
altered growth rates, likely a result of improper function
of TbRGG2 with the larger tag. Immunopuriﬁcation of
myc-TbRGG2 was carried out using untreated or nuclease
treated cell extracts, as previously described for the PTP-
tagged proteins. Interestingly, myc-TbRGG2 coprecipi-
tated endogenous TbRGG2 in an RNA-enhanced
manner (Figure 2A, lanes 7 and 8). This result suggests
that multiple TbRGG2 proteins, or TbRGG2-containing
complexes, can bind the same RNA or associated RNAs.
The core subcomplex proteins GAP1, GAP2 and
MRB3010 also demonstrate RNA-enhanced associations
with myc-TbRGG2 (Figure 2A, lanes 7 and 8), consistent
with the reciprocal PTP-MRB3010 pulldown described
above. The signal for MRB11870 in myc-TbRGG2
immunoprecipitates is low, and it is difﬁcult to discrimin-
ate between an RNA-enhanced or RNA-dependent asso-
ciation. These data further support an RNA-enhanced
interaction between TbRGG2 and the core subcomplex.
Table 2. Proteins associated with RNase-treated MRB1 components
were identiﬁed by LC–MS/MS
Locus tag Name/motif Unique
peptides
Amino acid
coverage (%)
PTP-MRB5390
Tb927.7.2570 GAP2 18 50.30
Tb927.5.3010 MRB3010 19 47.10
Tb11.02.5390 MRB5390 47 46.20
Tb927.10.11870 MRB11870 11 43.90
Tb11.01.8620 MRB8620 17 30.40
Tb927.2.3800 GAP1 15 30.30
Tb927.10.10130 MRB10130 8 18.90
Tb11.01.0880 MRB0880 2 13.20
Tb09.160.5320 PhyH 2 11.70
Tb927.7.800 MRB800 4 11.20
Tb927.8.8180 MRB8180 7 8.50
Tb10.406.0050 TbRGG2 1 4.10
Tb927.8.8170
Tb927.4.4160
MRB8170/MRB4160 1 2.40
Tb927.1.1730 1 2.30
PTP-MRB11870
Tb11.02.5390 MRB5390 32 33.10
Tb927.5.3010 MRB3010 15 32.60
Tb11.01.0880 MRB0880 3 32.20
Tb927.10.11870 MRB11870 10 31.90
Tb927.10.10130 MRB10130 11 26.40
Tb09.160.5320 PhyH 4 25.70
Tb11.01.8620 MRB8620 12 24.70
Tb927.7.800 MRB800 9 21.90
Tb927.2.3800 GAP1 10 19.70
Tb927.7.2570 GAP2 8 18.80
Tb927.8.8180,
Tb927.4.4150
MRB8180/MRB4150 10 13.10
Tb10.406.0050 TbRGG2 3 12.80
Tb927.2.1860 MRB1860 5 10.00
Tb927.7.5120 rRNA methylase 1 3.30
Tb927.8.8170,
Tb927.4.4160
MRB8170/MRB4160 1 2.40
PTP-MRB10130
Tb927.10.11870 MRB11870 11 48.40
Tb927.5.3010 MRB3010 21 46.50
Tb927.10.10130 MRB10130 19 45.90
Tb927.2.1860 MRB1860 22 34.20
Tb927.8.8180/ MRB8180/
Tb927.4.4150 MRB4150 26 32.30
Tb11.01.0880 MRB0880 4 32.20
Tb10.406.0050 TbRGG2 5 24.10
Tb927.7.800 MRB800 11 23.60
Tb927.2.3800 GAP1 8 22.80
Tb09.160.5320 PhyH 5 22.10
Tb11.02.5390 MRB5390 15 16.30
Tb927.7.2570 GAP2 6 15.60
Tb11.01.8620 MRB8620 6 13.70
Tb11.01.7290 MERS1 4 12.20
Tb927.3.1590 MRB1590 3 5.10
PTP-MRB6070
Tb927.2.6070 MRB6070 12 36.50
Tb10.70.0820 UMSBP, ZnF 2 30.50
Tb10.406.0050 TbRGG2 6 28.10
Tb927.10.7910 3 20.60
Tb927.7.2570 GAP2 5 19.00
Tb10.389.1410 ZnF 3 18.30
Tb11.01.7290 Nudix 4 15.70
Tb927.2.3800 GAP1 4 15.00
Tb927.4.4160 MRB4160 11 12.10
Tb927.8.8180,
Tb927.4.4150
MRB8180/MRB4150 8 11.30
Tb927.8.8170 MRB8170 8 9.60
Tb927.3.1590 MRB1590 3 8.50
(continued)
Table 2. Continued
Locus tag Name/motif Unique
peptides
Amino acid
coverage (%)
Tb11.01.0880 MRB0880 1 8.00
Tb927.10.11870 MRB11870 2 5.50
Tb10.61.1690 ZnF 1 4.60
Tb927.3.2300 ZnF 1 4.50
Tb927.5.3010 MRB3010 1 2.90
Tb927.7.800 MRB800 1 1.80
Tb11.02.5390 MRB5390 1 1.50
Mass spectrometric analysis of proteins identiﬁed in tandem afﬁnity
puriﬁcations of nuclease treated extracts from PF cells containing en-
dogenously PTP-tagged MRB1 complex components; MRB5390,
MRB11870, MRB10130 and MRB6070. The numbers of unique
peptides and amino acid coverage for each protein are shown.
Proteins highlighted in gray are components of the MRB1 core
complex.
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TbRGG2 also exhibited strong yeast two-hybrid inter-
actions with MRB8180, MRB10130, MRB4160 and
MRB8170, with the latter two displaying strong inter-
actions in both directions. The result of gene duplication
unique to T. brucei, MRB4160 and MRB8170 display
>80% homology and show a number of the same inter-
actions in yeast two-hybrid screens, including the core
protein MRB8620, TbRGG2 and MRB8170 itself
(Figure 1B). In addition, MRB8170 interacts with PPR1
and the core proteins MRB3010 and GAP1 (Figures 1B
and 2B). Interestingly, the existence of a subcomplex
comprising TbRGG2, MRB8170 and MRB4160 (green
in Figure 2B) was suggested by Madina et al. (29) based
on the isolation of these three proteins with the endonucle-
ase mRNP1, a non-MRB1 complex protein. The
TbRGG2-MRB8170 interaction is supported by western
blot analysis of myc-TbRGG2 pulldown, which shows an
RNA-enhanced TbRGG2-MRB8170 interaction, with a
large amount remaining after nuclease treatment (Figure
2A, lanes 7 and 8). Indeed, the diminished signal upon
nuclease treatment may reﬂect in part RNA-dependent
interactions between myc-TbRGG2 and TbRGG2–
MRB8170–MRB4160 complexes formed with the en-
dogenous TbRGG2 (Figure 2A, compare a-TbRGG2
and a-8170 in myc-TbRGG2 pull down lane).
Interactions between MRB8170 and the MRB1 core
subcomplex were probed by anti-MRB8170 western blot
analysis of PTP-MRB3010, PTP-MRB5390 and
PTP-MRB11870 puriﬁcations. The latter two proteins
exhibit an RNA-dependent association with MRB8170,
while PTP-MRB3010 demonstrated an RNA-enhanced
interaction with MRB8170 (Figure 2A, lanes 1–4). These
results are consistent with MRB8170 (and perhaps
MRB4160 and TbRGG2 in a subcomplex with it)
associating with the core, but not comprising part of the
core complex. Similar to TbRGG2, yeast two-hybrid
results indicate that the interaction of MRB8170 with
the core may be mediated by MRB3010 and MRB8620
(Figures 1B and 2B). Collectively, the yeast two-hybrid
screen and in vivo pulldown results suggest a model in
which TbRGG2, MRB8170, MRB4160 comprise a
subcomplex with primarily RNA-enhanced interactions
with the core subcomplex. In glycerol gradients,
MRB8170 partially cosedimented with the core proteins
MRB3010 and MRB11870 and TbRGG2 in fractions 11
and 13; however, MRB8170 peaked in fractions 7 and 9
(Figure 2C). These results suggest that MRB8170 engages
in dynamic interactions with the core and TbRGG2.
ARM/HEAT repeat protein MRB10130 mediates multiple
protein–protein interactions
In addition to the 31 strong interactions, yeast two-hybrid
analysis identiﬁed 31 weak interactions amongst the
MRB1 complex proteins (Figure 1B, diagrammed in
Figure 3A). MRB10130 is involved in 11 of these inter-
actions, demonstrating weak association with nine other
proteins, including numerous core components (GAP1,
MRB3010, MRB11870, MRB8620), TbRGG2,
MRB0880 [identiﬁed through its interactions with the
REH2 RNA helicase (13) and MRB3010 (14)], PPR5 [a
component of both MRB1 and kPAP1 complexes (12)],
MRB0130 [also a MERS1 complex component (12)] and
0024 [a component of both kPAP1 and MERS1
complexes (12)]. The observation that MRB10130
mediates numerous, diverse interactions is particularly
striking because analysis using the (PS)
2-v2 protein struc-
ture prediction server predicts that MRB10130 is almost
entirely composed of ARM/HEAT repeat units, which
often act as a protein–protein interaction platforms
(30,31). To determine if these weak interactions involving
MRB10130 are relevant in vivo, we generated PF T. brucei
cells expressing PTP-tagged MRB10130 and performed
pulldowns as described above. Mass spectrometric
analysis of PTP-MRB10130 that had been tandem
afﬁnity puriﬁed from nuclease treated cell extracts
identiﬁed a number of proteins that associated with
MRB10130 in the yeast two-hybrid analysis (Table 2).
This included TbRGG2, the only protein with which
MRB10130 showed strong interaction, as well as 5 of
the 9 proteins with which this protein exhibited weak
two-hybrid interactions (MRB11870, MRB3010, GAP1,
MRB8620 and MRB0880). PPR5, MRB0130, 7510 and
0024 were not identiﬁed in the pulldowns by mass spec-
trometry, yet they interacted with MRB10130 in
Figure 3. MRB10130 mediates multiple protein–protein interactions in
the MRB1 complex. (A) Schematic representation of all protein–protein
pairs exhibiting only weak interactions in the yeast two-hybrid screen.
Each black dashed line represents a weak interaction in one direction
and an underline represents self-interaction. (B) Puriﬁcation of
PTP-tagged MRB10130 from cell extracts that were either nuclease
treated (+ RNases) or left untreated (  RNases). TEV protease
eluates of IgG Sepharose 6 Fast Flow columns were analyzed by
immunoblot as described in Figure 2.
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sient in vivo interactions with MRB10130 that are lost in
the two-step puriﬁcation, or are simply false positives, has
yet to be determined. However, it is notable that we did
identify MERS1 by mass spectrometry of MRB10130
puriﬁcations, which could reﬂect an interaction mediated
by MRB0130 and/or 0024. Western blot analysis of TEV
eluates from PTP-MRB10130 puriﬁcations reveals
RNA-enhanced interactions between this protein and
MRB3010, GAP1, MRB8170 and TbRGG2 (Figure 3B).
These pulldowns thus support the in vivo relevance of the
weak yeast two-hybrid interactions with both the MRB1
core and the TbRGG2 subcomplex. Collectively, the yeast
two-hybrid and in vivo pulldown results suggest a role for
MRB10130 in mediating numerous protein–protein inter-
actions in the MRB1 complex, and possibly between
MRB1 and other RNA-modifying complexes.
RNA-dependent associations in the MRB1 complex
As stated above, 12 of the 31 proteins tested by yeast
two-hybrid analysis exhibited no interactions in this
assay, although most have been identiﬁed in more than
one MRB1 complex pulldown. This suggests that inter-
action of at least some of these proteins with the MRB1
core is entirely RNA-mediated. To test the
RNA-dependent associations of a protein lacking direct
interactions by yeast two-hybrid screen, we generated
antibodies against MRB6070 (10,13), and analyzed its
presence in untreated and nuclease treated MRB1 compo-
nent pulldowns. MRB6070 was present in pulldowns of
core components PTP-MRB3010 and PTP-MRB11870, as
well as PTP-MRB10130 pulldowns, when extracts were
untreated. However, MRB6070 was essentially absent if
the same pulldowns were performed after nuclease treat-
ment (Figure 2A, lanes 1 and 2, 5 and 6; Figure 3B).
Western blots of TEV elutions from PTP-MRB5390
pulldowns showed a very weak association with
MRB6070 in the presence or absence of RNase treatment;
however, no MRB6070 peptides were identiﬁed in the
mass spectrometric results (Figure 2A, lanes 3 and 4).
This is similar to the relatively weak interaction between
MRB5390 and TbRGG2, again suggesting that the tag on
MRB5390 may affect some of its in vivo interactions.
These results show that core proteins, MRB3010 and
MRB11870, as well as MRB10130 associate with
MRB6070 in a strictly RNA-dependent manner.
Consistent with these results, MRB6070 fractionated on
glycerol gradients in complexes of  11S, smaller than the
core proteins MRB3010 and MRB11870 (Figure 2C).
To further examine the interactions involving
MRB6070 in the MRB1 complex, we generated a PF
cell line expressing PTP-tagged MRB6070 and examined
eluates of tandem afﬁnity puriﬁcation by western blot and
mass spectrometry. Western blots of TEV elutions reveal
RNA-dependent interactions with core subcomplex GAP1
and GAP2, RNA-enhanced interactions with TbRGG2,
MRB8170 and endogenous MRB6070, but no interactions
with the core subcomplex proteins MRB3010 and
MRB11870 (Figure 4). Consistent with these results,
mass spectrometry of the anti-protein C elution from
RNase-treated PTP-MRB6070 extracts shows higher
coverage for GAP1, GAP2, TbRGG2 and MRB8170,
while MRB3010 and MRB11870 were identiﬁed by only
1 and 2 unique peptides, respectively (Table 2). The
apparent preferential association of GAP1 and GAP2
with PTP-MRB6070 as compared to other core compo-
nents supports our conclusion that the GAP1/2
heterotetramer can engage in interactions apart from the
core subcomplex. MRB6070 also pulled down MRB8180
and MRB4150, which may be a TbRGG2-interacting
protein (as suggested by yeast two-hybrid screen), and
MRB4160 which is believed to be in a subcomplex with
MRB8170 and TbRGG2 [Figure 1 and (29)]. Additional
MRB1 components MRB1590 and MERS1, which only
rarely copurify with the MRB1 complex are here pulled
down with MRB6070 (Table 2). Mass spectrometry also
identiﬁed a number of additional proteins that are not
members of the MRB1 complex copurifying with
PTP-MRB6070; most of these proteins contain zinc
ﬁnger (ZnF) motifs, including the universal
Figure 4. MRB6070 exhibits RNA-dependent interactions with MRB1
complex proteins. Puriﬁcation of PTP-tagged MRB6070 from cell
extracts that were either nuclease treated (+ RNases) or left untreated
(  RNases). Both the cell extracts (input) and the eluates from TEV
protease cleavage off IgG Sepharose columns (TEV elution) were
analyzed by immunoblot as described in Figure 2. Asterisks indicate
breakdown products.
5646 Nucleic Acids Research, 2012,Vol.40, No. 12minicircle-sequence binding protein (UMSBP). These
results are consistent with a model in which MRB6070
interacts with the MRB1 complex through association
with a common RNA. It is likely that a number of the
other proteins that only purify with a subset of the MRB1
pulldowns also have RNA-dependent associations with
the MRB1 complex.
DISCUSSION
MRB1 is a multifunctional complex with reported roles in
numerous aspects of mitochondrial gene expression,
including RNA editing and differing reported protein
compositions (10–17). In this study, we address the archi-
tecture of the MRB1 complex by identifying the direct and
indirect (protein- and RNA-mediated) interactions
between its component proteins to provide a roadmap
for understanding the function of the MRB1 complex
and constituent subcomplexes and proteins. We identiﬁed
a six-protein core subcomplex, containing GAP1, GAP2,
MRB3010, MRB5390, MRB8620 and MRB11870 that
interacts with other subcomplexes and proteins through
RNA-enhanced and RNA-dependent interactions. Yeast
two-hybrid and immunoblot analyses of afﬁnity puriﬁed
MRB1 complex proteins conﬁrmed numerous direct and
indirect interactions between the core complex proteins,
which are independent of RNA. These results validate
the consistent copuriﬁcation of these six proteins in
MRB1 pulldowns from various groups (10–14). The
core complex also has numerous and likely dynamic
interactions with other subcomplexes and proteins
involved in various processes including RNA processing,
polyadenylation, stabilization and editing (Figure 5).
What is unclear at this point is whether the core is a struc-
tural coordinator for all of the functions associated with
the MRB1 complex, whether it has a distinct function of
its own, or if the core is responsible for both of these
activities.
Although the function of the core complex as a whole is
not known, some of its component proteins have been
characterized. Knockdown experiments show that both
MRB5390 and MRB3010 affect RNA editing of most
transcripts, with MRB3010 having a role at an early
step in the editing process (14,16). Knockdowns of
GAP1 and GAP2 primarily cause destabilization of
gRNAs, which was not seen with the MRB3010
knockdowns (12,14,17). Thus, while these proteins are
all components of the core MRB1 complex, they appear
to affect different steps of the editing process. This may in
part be a result of using knockdowns to analyze protein
function. With this method, not only do we observe the
in vivo effect of the direct loss of the protein’s activity, but
if the protein has binding partners we may also see the
effect of the loss of these interactions. Therefore, knocking
down the protein results in phenotypes summarizing
compromised function of some or all of the proteins it
touches, highlighting the critical nature of the structural
analysis undertaken in this study.
GAP1 and GAP2 form an a2/b2 heterotetramer that
binds gRNAs in vitro and in vivo (12,32), and is likely
responsible for mediating the interaction of the core
complex with gRNAs. The inhibition of editing at an
early stage by MRB3010 knockdowns suggests that one
function of the core may be to recruit GAP1/2-bound
Figure 5. Model for MRB1 complex interactions. The core complex binds gRNA through GAP1/2. The TbRGG2 subcomplexes interact with the
core and RNA. MRB6070 associates with the MRB1 complex in an RNA-dependent manner. The gray arrows and question marks indicate
remaining questions regarding whether TbRGG2 subcomplexes and MRB6070 bind gRNA, mRNA, or both. MRB10130 binds the core,
TbRGG2 subcomplex, MERS1 complex and kPAP1 complex and may coordinate association of these proteins. Because repression of numerous
MRB1 components affects RNA editing, the MRB1 complex presumably interacts transiently with the RECC, as suggested by several studies.
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GAP1/2 can also exist as a subcomplex apart from the
core as evidenced by their enriched puriﬁcation in the
MRB6070 pulldown separate from the rest of the core
(Table 2) as well as sedimentation separate from other
core complex components (Figure 2C). Perhaps GAP1/2
exists as a heterotetramer when it initially binds the gRNA
and then brings it to the core complex, although add-
itional core proteins could facilitate GAP1/2-gRNA inter-
action. Interestingly, although GAP1 and GAP2 have
31% sequence identity and 48% sequence similarity,
only GAP1 displayed interactions in the yeast two-hybrid
screen. Although false negative results occur in yeast
two-hybrid screens, our results may indicate that GAP1
is responsible for all protein interactions of the
heterotetramer.
A number of other proteins demonstrated interaction
with the core complex in our study, including TbRGG2.
Indeed, apart from the core complex proteins, TbRGG2
and its interacting proteins are responsible for most of the
remaining strong interactions by yeast two-hybrid screen.
TbRGG2 and the paralogs MRB8170 and MRB4160 ex-
hibited multiple interactions with each other and, thus,
may exist as a subcomplex, although we cannot distin-
guish between multiple binary complexes or a single
subcomplex containing these proteins from our results.
Support for a TbRGG2 subcomplex, or subcomplexes,
comes from the recent report that only TbRGG2,
MRB8170 and MRB4160 copuriﬁed with the
endoribonuclease mRNP1, which is involved in gRNA
processing (29). Together, these data suggest these three
proteins exist together apart from the rest of the MRB1
complex. Interestingly, the TbRGG2 subcomplex(es) con-
taining MRB8170 and MRB4160 may not be the only
subcomplex carrying TbRGG2. Mass spectrometry
results from tandem afﬁnity puriﬁcations of MRB10130
(a protein that has a strong interaction with TbRGG2 by
yeast two-hybrid) revealed high amino acid coverage for
TbRGG2; however, MRB8170 and MRB4160 were not
present (Table 2). Rather, in these MRB10130 pulldowns,
another protein that had a strong interaction with
TbRGG2 in the yeast two-hybrid screen, MRB8180, ex-
hibited high amino acid coverage comparable to that of
TbRGG2 (Table 2). Additionally, TbRGG2 and
MRB8170 had overlapping but distinct sedimentation
patterns (Figure 2C). Thus, TbRGG2 may have multiple
subcomplex associations within the MRB1 complex. The
complexity of the TbRGG2 interactions in the MRB1
complex adds to the difﬁculty in determining the role of
TbRGG2 in RNA editing. It is known that TbRGG2 is a
multifunctional protein that affects gRNA utilization
and editing processivity (15). However, the speciﬁc func-
tions of the TbRGG2 subcomplex(es) or its binding
partners including MRB8170, MRB4160, MRB8180
and MRB10130 are unknown. Although the TbRGG2
subcomplex(es) containing MRB8170 and MRB4160
was found associated with mRPN1, an endonuclease
involved in gRNA processing, RNAi results for
TbRGG2 suggest that gRNA processing is not one of its
primary functions (15). TbRGG2 has two putative
RNA-BDs, and in vitro binds RNA (23), so we postulate
that TbRGG2 is one of the proteins responsible for
MRB1 complex binding to RNA, possibly facilitating
gRNA or mRNA association and utilization during
editing. Where and when the different TbRGG2-binding
partners play a role has yet to be determined, and we
speculate that there may be temporal differences in these
TbRGG2 associations.
The results discussed thus far suggest the occurrence of
dynamic associations within the MRB1 complex, particu-
larly with the core. Likely there are proteins whose
purpose is to coordinate these interactions and processes,
and an attractive candidate for this role is MRB10130.
This protein is predicted on TriTrypDB to consist
mostly of an ARM repeat Superfamily SSF48371
domain, and modeling analysis reveals that the majority
of the protein forms HEAT repeats. ARM Superfamily
proteins (which includes HEAT motif-containing
proteins), often act as organizers of protein complexes
because the superhelix of a-helices and hydrophobic core
formed by tandem ARM repeat units creates a versatile
platform for interactions with numerous partners (33–37).
In fact, MRB10130 has numerous yeast two-hybrid inter-
acting partners, all of which display weak interactions
except for TbRGG2. Immunopuriﬁcation experiments
demonstrate clear association of MRB10130 with the
core complex, TbRGG2 subcomplex(es), other MRB
proteins and the MERS1 Nudix hydrolase. Could
MRB10130 be facilitating binding of speciﬁc proteins
with the core or the TbRGG2 subcomplex (Figure 5)?
Could MRB10130 be coordinating association of the
core and TbRGG2 subcomplex with each other? Does
MRB10130 play a role in coordinating association of the
kPAP1 and MERS1 complexes with the core? Further
analysis is necessary to determine if MRB10130 is acting
as an MRB1 complex organizer and how cooperative and/
or competitive protein binding to MRB10130 plays a role.
Finally, a number of proteins previously identiﬁed in
MRB1 pulldowns were included in our yeast two-hybrid
screen, but exhibited no direct interactions in this assay. In
some cases, this may be the result of false negatives;
however, we anticipate that a number of these proteins
have only RNA-dependent or transient interactions with
the MRB1 complex. Likely, numerous RNA-binding
proteins interact with gRNAs and mRNAs and through
this associate with the MRB1 complex. Whether these
proteins are essential for some of the functions carried
out by the MRB1 complex has not been addressed. In
this study, we identiﬁed an RNA-dependent component
of the MRB1 complex, termed MRB6070. MRB6070 is
predicted to contain 5–6 repeats of a Ran-binding
protein 2 type ZnF domain which can act as either a
protein recognition motif or a single-stranded RNA-
binding motif (38). The fact that the yeast two-hybrid
screen revealed no direct protein interactions with
MRB6070, yet in pulldown experiments this protein con-
sistently displayed RNA-dependent and RNA-enhanced
interactions with other MRB1 proteins, suggests the
ZnF motifs in MRB6070 function in RNA binding.
Western blot analysis provided additional evidence for
RNA-dependent association of MRB6070 with the
MRB1 complex (Figures 2A and 3B), yet it remains
5648 Nucleic Acids Research, 2012,Vol.40, No. 12unknown if MRB6070 is interacting through mRNA,
gRNA, or both (Figure 5). When MRB6070 was tandem
afﬁnity puriﬁed, mass spectrometry of associated proteins
revealed primarily the RNA-binding proteins of the
MRB1 complex (GAP1, GAP2, TbRGG2). The
copuriﬁcation of TbRGG2 and MRB8170 with
PTP-MRB6070 after RNase treatment suggests these
proteins are in close proximity on the same RNA, and
thus the interactions are partially resistant to RNAse
treatment (Figure 4), although we cannot exclude a
direct interaction undetected by yeast two-hybrid
analysis. The tandem afﬁnity puriﬁcation of
PTP-MRB6070 also identiﬁed a number of other likely
nucleic acid-binding proteins that were not previously
identiﬁed as part of the MRB1 complex, including the
UMSBP. The association of MRB6070 with UMSBP
may be a result of either MRB6070 binding to nascent
minicircle-encoded RNA, DNA-binding activity of
MRB6070 and resultant interaction with UMSBP on the
minicircle, or a role for UMSBP outside of DNA replica-
tion in which it interacts with MRB6070.
In conclusion, the present study provides signiﬁcant
insight into the direct and indirect interactions within
the MRB1 complex. Our results suggest a dynamic
complex comprised of subcomplexes and RNA-binding
proteins that are likely subject to temporal and spatial
regulation as they carry out numerous functions in mito-
chondrial gene regulation. The interaction studies
described here illuminate potential functions of the
MRB1 complex components, such as a direct role for
the core in gRNA recruitment during RNA editing and
a role for MRB10130 in MRB1 complex organization.
They further provide a framework for the future interpret-
ation of functional studies of proteins that comprise this
enigmatic complex.
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